Derleme
BibTex RIS Kaynak Göster

Yıl 2021, Cilt: 38 Sayı: 2s, 44 - 52, 18.03.2021

Abdullah Emre Yıldırım

Öz

Destekleyen Kurum

yok

Teşekkür

Doç Dr. Talat Ayyıldız

Kaynakça

  • Abdulsamad, M., Reddy, P., Guvvala, S., Dev, A., 2017. Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography with Sphincterotomy in a Patient with Choledocholithiasis and Unusual Coagulopathy. Gastroenterology Res. 10, 144–146.

ERCP-Related Bleeding

Yıl 2021, Cilt: 38 Sayı: 2s, 44 - 52, 18.03.2021

Abdullah Emre Yıldırım

Öz

Clinically significant bleeding is an uncommon complication of diagnostic endoscopic retrograde cholangiopancreatography. But the endoscopists needs to be skilled at prevention and management. Post ERCP bleeding is most often seen following sphincterotomy. The overall risk of bleeding in patients undergoing sphincterotomy is approximately 1-2 percent. Most bleeding episodes are mild to moderate in severity. The risk of bleeding can be minimized by identifying patients at risk, correcting coagulation abnormalities and careful technique by skilled endoscopists in high-volume centers. Post-sphincterotomy bleeding often stops spontaneously and is rarely life-threatening, except in patients with a bleeding diathesis. Most clinically relevant bleedings can be managed with medical treatment and/or endoscopic therapy, which should be performed without delay in patients who have immediate bleeding. Endoscopic therapy options include epinephrine
injection, hemostatic clips, thermal therapy and placement of full covered self-expandable metal stents. Angiography or surgery is usually reserved for patients with refractory bleeding and is rarely required.

Anahtar Kelimeler

ERCP ERCP adverse event ERCP Bleeding, Post ERCP haemorrhage

Kaynakça

  • Abdulsamad, M., Reddy, P., Guvvala, S., Dev, A., 2017. Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography with Sphincterotomy in a Patient with Choledocholithiasis and Unusual Coagulopathy. Gastroenterology Res. 10, 144–146.
Toplam 1 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Clinical Research
Yazarlar

Abdullah Emre Yıldırım 0000-0002-4386-9297

Yayımlanma Tarihi 18 Mart 2021
Gönderilme Tarihi 20 Temmuz 2020
Kabul Tarihi 10 Kasım 2020
Yayımlandığı Sayı Yıl 2021 Cilt: 38 Sayı: 2s

Kaynak Göster

APA Yıldırım, A. E. (2021). ERCP-Related Bleeding. Journal of Experimental and Clinical Medicine, 38(2s), 44-52.
AMA Yıldırım AE. ERCP-Related Bleeding. J. Exp. Clin. Med. Mart 2021;38(2s):44-52.
Chicago Yıldırım, Abdullah Emre. “ERCP-Related Bleeding”. Journal of Experimental and Clinical Medicine 38, sy. 2s (Mart 2021): 44-52.
EndNote Yıldırım AE (01 Mart 2021) ERCP-Related Bleeding. Journal of Experimental and Clinical Medicine 38 2s 44–52.
IEEE A. E. Yıldırım, “ERCP-Related Bleeding”, J. Exp. Clin. Med., c. 38, sy. 2s, ss. 44–52, 2021.
ISNAD Yıldırım, Abdullah Emre. “ERCP-Related Bleeding”. Journal of Experimental and Clinical Medicine 38/2s (Mart 2021), 44-52.
JAMA Yıldırım AE. ERCP-Related Bleeding. J. Exp. Clin. Med. 2021;38:44–52.
MLA Yıldırım, Abdullah Emre. “ERCP-Related Bleeding”. Journal of Experimental and Clinical Medicine, c. 38, sy. 2s, 2021, ss. 44-52.
Vancouver Yıldırım AE. ERCP-Related Bleeding. J. Exp. Clin. Med. 2021;38(2s):44-52.
 Kapak Resmi İndir

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.